France· FR:65241522

MEROPENEM ARROW LAB 1 g, poudre pour solution injectable/pour perfusion

A meropenem product containing méropénem trihydraté, registered in France by EUGIA PHARMA (MALTA) (MALTE), on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC J01DH02

Checked against Base de données publique des médicaments — BDPM (France) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about méropénem trihydratéAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Meropenem is registered in 18 of 19 countries.

Countries holding a registration under ATC J01DH02 (meropenem), each read from that country’s own register.

This record: France, from Base de données publique des médicaments — BDPM (France)
10 of them publish a price we can compare per daily dose

Search meropenem products by name

Meropenem · ATC J01DH02

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of meropenem costs, country by country.

Normalised to the WHO defined daily dose (3 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Meropenem · price per daily dose (3 g)

USD · FX 28 Sept 2026

CH Switzerland$99.79

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)

Active substance: MÉROPÉNEM TRIHYDRATÉ
Manufacturer: EUGIA PHARMA (MALTA) (MALTE)
Country: France (FR)
ATC code: J01DH02
ATC class: Meropenem
Defined daily dose: 3 g, P
Reimbursed: Yes
Source register: Base de données publique des médicaments — BDPM (France)
Last checked: September 12, 2026

Packs & prices · 1

1 priced

cip13
3400930088272
10 flacon(s) en verre de 1349,56 mg
EUR 141.77

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

25 interactions on record for meropenem.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check meropenem against other medicines How interaction checks work

Meropenem · interactions on record

25 records

4 severe
20 moderate

Most severe, free to view

BupropionN06AX12severe
BupropionN07BA02severe
IohexolV08AB02severe
IopamidolV08AB04severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Meropenem in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All meropenem products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Merinfec, Meropenem Aptapharma
Belgium · Meronem Iv, Meropenem Bradex
Bulgaria · Meropenem Kabi, Meropenem-Tchaikapharma
Cyprus · Archifar, Meropenem Aptapharma
Czechia · Archifar, Meronem
Germany · Meropenem, Meropenem Acs Dobfar
Denmark · Merocarb, Meropenem "thrive"
Estonia · Agenor, Meropenem Bausch Health
Spain · Archifar, Meropenem Aurovit
Finland · Merocarb, Meropenem Aptapharma
United Kingdom (Northern Ireland) · Meronem Iv, Meropenem
Greece · Carbenem, Homepen
Croatia · Archifar, Meropenem Aptapharma
Hungary · Meropenem Aptapharma, Meropenem Bradex
Ireland · Meronem I.V., Meropenem
Iceland · Merinfec, Merocarb
Italy · Luxomer, Meropenem Acs Dobfar
Lithuania · Agenorem, Meropenem Kabi
Luxembourg · Meronem Iv, Meropenem Bradex
Latvia · Archifar, Meropenem Kabi
Malta · Archifar, Mepenex
Netherlands · Meropenem Aptapharma, Meropenem Bradex
Norway · Merocarb, Meropenem Aptapharma
Poland · Meronem, Meropenem Aptapharma
Portugal · Meropenem Atral, Meropenem Aurovitas
Romania · Archifar, Loditer
Sweden · Merocarb, Meronem
Slovenia · Archifar, Meropenem Actavis
Slovakia · Archifar, Merocarb

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/48468b97-f85d-4300-af3c-596d2bdf4b20
GET /v1/drugs/48468b97-f85d-4300-af3c-596d2bdf4b20?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65241522",
  "date_amm": "2017-05-05",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "MÉROPÉNEM TRIHYDRATÉ",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution injectable ou pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

API reference MCP server Plans

See everything about meropenem.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console